Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of ziprasidone treatment versus treatment with a
standard atypical antipsychotic drug in improving insulin sensitivity and reducing excess
abdominal fat storage in people with schizophrenia who are at risk for diabetes.